SCHEMBL7079702

SCHEMBL7079702

O=C(Nc1ccc(Cc2ccccn2)cc1)c1ccccc1-c1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
HTT P42858 1/20 0.49
SMO Q99835 2/20 0.48
ALDH1A1 P00352 1/20 0.47
CHRNB2 P17787 2/20 0.46
CHRNB4 P30926 2/20 0.46
CHRNA3 P32297 2/20 0.46
CHRNA4 P43681 2/20 0.46
GRM4 Q14833 1/20 0.46
MAPT P10636 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 2/20 0.45
RAB9A P51151 2/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6793867 0.90 HTT (0.62) LMNAHTTSMOALDH1A1CHRNB2
SCHEMBL6793016 0.88 ALDH1A1 (0.61) LMNAHTTSMOALDH1A1CHRNB2
SCHEMBL6788071 0.86 KDM4E (0.51) LMNAHTTSMOALDH1A1CHRNB2
SCHEMBL6799666 0.86 TDP1 (0.54) LMNAHTTSMOALDH1A1CHRNB2
SCHEMBL6794025 0.83 LMNA (0.48) LMNAHTTSMOALDH1A1CHRNB2
SCHEMBL6800986 0.83 GAA (0.64) LMNAHTTSMOALDH1A1MAPT
SCHEMBL6793244 0.83 SMO (0.62) LMNAHTTSMOALDH1A1SMN1; SMN2
SCHEMBL6200210 0.83 CHRNB2 (0.66) LMNAHTTALDH1A1CHRNB2CHRNB4
SCHEMBL6792646 0.82 LMNA (0.47) LMNAHTTSMOALDH1A1CHRNB2
SCHEMBL6788429 0.81 KDR (0.52) LMNAHTTSMOALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed